Joman Natsheh, M.D. - Publications

Affiliations: 
Center for Molecular and Behavioral Neuroscience Rutgers The State University of New Jersey - Newark, United States 

7 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Natsheh JY, Espinoza D, Bhimani S, Shiflett MW. The effects of the dopamine D2/3 agonist quinpirole on incentive value and palatability-based choice in a rodent model of attention-deficit/hyperactivity disorder. Psychopharmacology. PMID 34313801 DOI: 10.1007/s00213-021-05931-7  0.597
2020 Favier M, Janickova H, Justo D, Kljakic O, Runtz L, Natsheh JY, Pascoal TA, Germann J, Gallino D, Kang JI, Meng XQ, Antinora C, Raulic S, Jacobsen JP, Moquin L, et al. Cholinergic dysfunction in the dorsal striatum promotes habit formation and maladaptive eating. The Journal of Clinical Investigation. PMID 33164988 DOI: 10.1172/JCI138532  0.303
2020 Ceceli AO, Natsheh JY, Cruz D, Tricomi E. The neurobehavioral mechanisms of motivational control in attention-deficit/hyperactivity disorder. Cortex; a Journal Devoted to the Study of the Nervous System and Behavior. 127: 191-207. PMID 32222572 DOI: 10.1016/J.Cortex.2020.02.009  0.516
2018 Natsheh JY, Shiflett MW. Dopaminergic Modulation of Goal-Directed Behavior in a Rodent Model of Attention-Deficit/Hyperactivity Disorder. Frontiers in Integrative Neuroscience. 12: 45. PMID 30344481 DOI: 10.3389/Fnint.2018.00045  0.624
2015 Natsheh JY, Shiflett MW. The Effects of Methylphenidate on Goal-directed Behavior in a Rat Model of ADHD. Frontiers in Behavioral Neuroscience. 9: 326. PMID 26635568 DOI: 10.3389/Fnbeh.2015.00326  0.591
2013 Herzallah MM, Moustafa AA, Natsheh JY, Abdellatif SM, Taha MB, Tayem YI, Sehwail MA, Amleh I, Petrides G, Myers CE, Gluck MA. Learning from negative feedback in patients with major depressive disorder is attenuated by SSRI antidepressants. Frontiers in Integrative Neuroscience. 7: 67. PMID 24065894 DOI: 10.3389/Fnint.2013.00067  0.41
2013 Herzallah MM, Moustafa AA, Natsheh JY, Danoun OA, Simon JR, Tayem YI, Sehwail MA, Amleh I, Bannoura I, Petrides G, Myers CE, Gluck MA. Depression impairs learning, whereas the selective serotonin reuptake inhibitor, paroxetine, impairs generalization in patients with major depressive disorder. Journal of Affective Disorders. 151: 484-92. PMID 23953023 DOI: 10.1016/J.Jad.2013.06.030  0.43
Show low-probability matches.